Sign in

CIK 0001672619

  • Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811523849
Phone
+1 650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
  1. 4 Planned sale CHIEF OPERATING OFFICER sold 716 shares at $30.00 ($21,483)
  2. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 847 shares at $30.00 ($25,413)
  3. 4 Planned sale PRESIDENT AND CEO sold 924 shares at $30.00 ($27,723)
  4. 4 Planned sale CHIEF FINANCIAL OFFICER sold 814 shares at $30.00 ($24,422)
  5. 4 Planned sale Director sold 1,570 shares at an average $30.00 ($47,104)
  6. 4 Planned sale CHIEF MEDICAL OFFICER sold 816 shares at $30.00 ($24,482)
  7. 4 Planned sale Director sold 1,270 shares at $27.67 ($35,143)
  8. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 51,145 shares at an average $28.11 ($1,437,585)
  9. 4 Planned sale PRESIDENT AND CEO sold 29,977 shares at an average $28.07 ($841,334)
  10. 4 Planned sale Director sold 10,420 shares at $28.17 ($293,557)
  11. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 10,229 shares at an average $27.54 ($281,664)
  12. 4 Planned sale PRESIDENT AND CEO sold 14,936 shares at an average $27.51 ($410,867)
  13. 4 Planned sale CHIEF FINANCIAL OFFICER sold 11,488 shares at an average $27.51 ($316,014)
  14. 4 Planned sale Director sold 2,825 shares at $27.51 ($77,704)
  15. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 527 shares at $27.54 ($14,512)
  16. 4 Planned sale PRESIDENT AND CEO sold 526 shares at $27.54 ($14,485)
  17. 4 Planned sale CHIEF FINANCIAL OFFICER sold 521 shares at $27.54 ($14,347)
  18. 4 Planned sale Director sold 518 shares at $27.54 ($14,264)
  19. 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,250 shares at an average $24.61 ($153,829)
  20. 4 Planned sale Director sold 1,270 shares at $22.41 ($28,458)

Page 7 of 20 · 383 filings